Kiniksa Pharmaceuticals

$16.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.58 (-8.93%) As of 7:57 PM UTC today

Why Robinhood?

You can buy or sell KNSA and other stocks, options, and ETFs commission-free!

About KNSA

Kiniksa Pharmaceuticals, Ltd. Class A Common Stock, also called Kiniksa Pharmaceuticals, is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

CEO

Sanj K. Patel

Employees

168

Headquarters

Hamilton, Hamilton

Founded

2015

Market Cap

1.08B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

605.90K

High Today

$17.71

Low Today

$15.91

Open Price

$17.70

Volume

678.65K

52 Week High

$28.67

52 Week Low

$14.51

KNSA Earnings

-$0.79

-$0.53

-$0.26

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected Apr 28, Pre-Market